Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality

Journal of Leukocyte Biology

Volumn 91, Issue 4, 2012, Pages 629-639

  Castor, Marina G M ^a   Rezende, Barbara M ^a   Resende, Carolina B ^a   Bernardes, Priscila T T ^a   Cisalpino, Daniel ^a   Vieira, Angèlica T ^a   Souza, Danielle G ^a   Silva, Tarcília A ^a   Teixeira, Mauro M ^a   Pinho, Vanessa ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; LIPID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BIOACCUMULATION; BONE MARROW TRANSPLANTATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM; GRAFT VERSUS HOST REACTION; INFLAMMATION; INTESTINE; INTRAVITAL MICROSCOPY; LETHALITY; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; LIVER; MESENTERY BLOOD FLOW; MICROSCOPY; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL; TARGET ORGAN; TISSUE INJURY;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW TRANSPLANTATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKOCYTES; MALE; MICE; MICE, KNOCKOUT; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

BACTERIA (MICROORGANISMS); MUS;

EID: 84860843379     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1111561     Document Type: Article

References (49)

1. Ferrara, J. L., Levine, J. E., Reddy, P., Holler, E. (2009) Graft-versus-host disease. Lancet 373, 1550-1561.
2. Jaksch, M., Mattsson, J. (2005) The pathophysiology of graft-versus-host disease. Scand. J. Immunol. 61, 398-409.
3. Will, A., Wynn, R. (2006) Diagnosis of acute graft-versus-host disease. Transplantation 81, 505-506.
4. Goker, H., Hanznedaroglu, I. C, Chao, N.J. (2001) Acute graft-vs-host disease: pathobiology and management. Exp. Hematol. 29, 259-277.
5. Wysocki, C. A, Panoskalsis-Mortari, A, Blazar, B. R, Serody, J. S. (2005) Leukocyte migration and graft-versus-host disease. Blood 105, 4191-4199.
6. Serody, J. S., Burkett, S. E., Panoskaltsis-Mortari, A, Ng-Cashin, J., McMahon, E., Matsushima, G. R, Lira, S. A, Cook, D. N., Blazar, B. R (2000) T-lymphocyte production of macrophage inflammatory protein-1a is critical to recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 96, 2973-2980.
7. Castor, M. G., Rezende, B., Resende, C. B., Alessandri, A. L., Fagundes, C. T., Sousa, L. P., Arantes, R. M., Souza, D. G., Silva, T. A, Proudfoot, A. E., Teixeira, M. M., Pinho, V. (2010) The CCL3/macrophage inflammatory protein-1a-binding protein evasin-1 protects from graft-versus-host disease but does not mModify graft-versus-leukemia in mice. J. Immunol. 184, 2646-2654.
8. Castor, M. G. M., Rezende, B., Bernardes, P. T. T., Vieira, T. A, Arantes, R M. E., Souza, D. G., Silva, T. A, Teixeira, M. M., Pinho, V. (2011) PI3K7 controls leukocyte recruitment, tissue injury and lethality in a model of graft versus host disease in mice. J. Leukoc. Biol. 89, 955-964.
9. Ishii, S., Nagase, T., Shimizu, T. (2002) Platelet-activating factor receptor. Prostglandins Other Lipid Mediat. 68-69, 599-609.
10. Honda, Z., Ishii, S., Shimizu, T. (2002) Platelet-activating factor receptor. J. Biochem. 131, 773-779.
11. Prescott, S. M., Zimmerman, G. A, Stafforini, D. M., McIntyre, T. M. (2000) Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69, 419-445.
12. Coelho, F. M., Pessini, A. C, Coelho, A. M., Pinho, V. S., Souza, D. G., Arantes, E. C, Teixeira, M. M., Teixeira, A. L. (2007) Platelet activating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom. Toxicon 50, 420-427.
13. Souza, D. G., Pinho, V., Soares, A. C, Shimizu, T., Ishii, S., Teixeira, M. M. (2003) Role of PAF receptors during intestinal ischemia and reper-fusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br. J. Pharmacol. 139, 733-740.
14. Souza, D. G., Cara, D. C, Cassali, D. G., Coutinho, S. F., Silveira, M. R, Andrade, S. P., Poole, S. P., Teixeira, M. M. (2000) Effects of the PAF receptor antagonist UK 74505 on local and remote reperfusion injuries following ischemia of the superior mesenteric artery in the rat. Br. J. Pharmacol 131, 1800-1808.
15. Lorant, D. E., Topham, M. K, Whatley, R. E., McEver, R P., Mcintyre, T. M. (1993) Inflammatory roles of P-selectin. J. Clin. Invest. 92, 559-570.
16. Macconi, D., Foppolo, M., Paris, S., Noris, M., Aiello, S., Remuzzi, G., Re-muzzi, A. (1995) PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. Am. J. Physiol. 269, 42-47.
17. Landgraf, R. G., Nossi, D. F., Sirois, P., Jancar, S. (2007) Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in murine model of asthma. Prostaglandins Leukot. Essent. Fatty Acids 77, 163-172.
18. Klein, A., Pinho, V., Alessandrini, A. L., Shimizu, T., Ishii, S., Teixeira, M. M. (2002) Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. Br. J. Pharmacol. 135, 1213-1218.
19. Soares, A. C, Pinho, V. S., Souza, D. G., Shimizu, T., Ishii, S., Nicoli, J. R, Teixeira, M. M. (2002) Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria. Br. J. Pharmacol. 137, 621-628.
20. Garcia, C. C, Russo, R C, Guabiraba, R, Fagundes, C. T., Polidoro, R B., Tavares, L. P., Salgado, A. P., Cassali G. D., Sousa L. P., Machado, A. V., Teixeira, M. M. (2010) Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. PLoS Pathog. 6, e1001171.
21. Souza, D. G., Fagundes, C. T., Sousa, L. P., Amaral, F. A., Souza, R S., Souza, A. L., Kron, E. G., Sachs, D., Cunha, F. Q., Bukin, E., Atrasheus-kaya, A., Ignatyev, G., Teixeira, M. M. (2009) Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc. Natl. Acad. Sci. USA 106, 14138-14143.
22. Ishii, S., Shimizu, T (2000) Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39, 41-82.
23. Ortega, M. P., García, M.C., Gijon, M. A., de Casa-Juana, M. F., Priego, J. G., Sanchez Crespo, M., Sunkel, C. (1999) 1,4-Dihydropyridines, a new class of platelet activating factor receptor antagonists: in vitro pharmacological studies. J. Pharmacol. Exp. Ther. 255, 28-33.
24. Fernandez-Gallardo, S., Ortega, M. P., Priego, J. G., de Casa-Juana, M. F., Sunkel, C, Sanchez Crespo, M. (1990) Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies. J. Pharmacol. Exp. Ther. 255, 34-39.
25. Hasegawa, S., Kohro, Y., Shiratori, M., Ishii, S., Shimizu, T., Tsuda, M., Inoue, K (2010) Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. PLoS One 5, e10467.
26. Jones, J. M., Wilson, R, Bealmear, P. M. (1971) Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat. Res. 45, 577-588.
27. Beelen, D. W., Elmaagacli, A., Muller, K D., Hirche, H., Schaefer, U. W. (1999) Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 93, 3267-3275.
28. Beelen, D. W., Haralambie, E., Brandt, H., Linzenmeier, G., Muller, K D., Quabeck, K, Sayer, H. G., Graeven, U., Mahmoud, H. K, Schaefer, U. W. (1992) Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 80, 2668-2676.
29. Ellison, C. A., Fischer, J. M., HayGlass, K T., Gartner, J. G. (1998) Murine graft-versus-host disease in an F1-hybrid model using IFN-γ gene knockout donors. J. Immunol. 161, 631-640.
30. Irani, J. L., Cutler, C. S., Whang, E. E., Clancy, T. E., Russel, S., Swanson, R S., Ashley S. W., Zinner, M. J., Raut, C. P. (2008) Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care. Arch. Surg. 143, 1041-1045.
31. Bouazzaoui, A., Spacenko, E., Muller, G., Miklos, S., Huber, E., Holler, E., Andreesen, R, Hildebrandt, G. C. (2009) Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes Immun. 10, 687-701.
32. Ellison, C. A., Natuik, S. A., Mcintosh, A. R, Scully, S. A., Danilenkos, D. M., Gartner, J. G. (2003) The role of interferon-γ, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice. Immunology 109, 440-449.
33. Niederwieser, D., Herold, M., Woloszczuk, W., Aulitzky, W., Meister, B., Tilg, H., Gastl, G., Bowden, R, Huber, C. (1990) Endogenous IFN-γ during human bone marrow transplantation. Transplantation 50, 620-625.
34. Ellison, C. A., Fischer, J. M. M., HayGlass, K T., Gartner, J. G. (1998) Murine graft-versus-host disease in an F1-hybrid model using IFN-γ gene knockout donors. J. Immunol. 161, 631-640.
35. Mowat, A M. (1989) Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 68, 18-23.
36. Cooke, K R., Hill, G R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte Jr., J., Ferrara, J. L. (1998) Tumor necrosis factor-a production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J. Clin. Invest. 102, 1882-1891.
37. Jacobsohn, D. A., Vogelsang, G. B. (2004) Anti-cytokine therapy for the treatment of graft-versus-host disease. Curr. Pharm. Des. 10, 1195-1205.
38. El-Hayek, J. M., Rogers, T E., Brown, J. R (2005) The role of TNF in hepatic histopatological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD. J. Leukoc. Biol. 78, 1001-1007.
39. Choi, S. W., Hildebrandt, G. C, Olkiewicz, K M., Hanauer, D. A., Chaud-hary, M. N., Silva, I. A., Rogers, C. E., Deurloo, D. T., Fisher, J. M., Lui, C, Adams, D., Chensue, S. W., Cooke, K R (2007) CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation. Blood 110, 3447-3455.
40. Liu, S. X., Tian, R, Baskind, H., Hsueh, W., De Plaen, I. G. (2009) Platelet-activating factor induces the processing of nuclear factor-KB p105 into p50, which mediates acute bowel injury in mice. Am. J. Physiol. Gastroin-test. Liver Physiol. 297, G76-G81.
41. Ferreira, M. A., Barcelos, L. S., Teixeira, M. M., Bakhle, Y S., Andrade, S. P. (2007) Tumor growth, angiogenesis and inflammation in mice lacking receptor for platelet activating factor (PAF). Life Sci. 81, 210-217.
42. Han, X. B., Liu, X., Hsueh, W., De Plaen, I. G. (2004) Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1220-G1226.
43. Maruoka, S., Hashimoto, S., Gon, Y, Takeshita, I., Horie, T. (2000) PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. Am. J. Respir. Crit. Care Med. 161, 922-929.
44. Jocks, T., Freudenberg, J., Zahner, G., Stahl, R A. (1998) Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury. Nephrol. Dial. Transplant. 13, 37-43.
45. Rezvani, K, Barrett, J. (2008) Characterizing and optimizing immune responses to leukemia antigens after allogeneic stem cell transplantation. Best Pract. Res.Clin. Haematol. 21, 437-453.
46. Johnson, B. D., Becker, E. E., Truitt, R L. (1999) Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol. Blood Marrow Transplant. 5, 123-132.
47. Johnson, B. D., Truitt, R L. (1992) A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. Transplantation 54, 104-112.
48. Johnson, B. D., Drobyski, W. R, Truitt, R L. (1993) Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant. 11, 329-336.
49. Johnson, B. D., Dagher, N., Stankowski, W. C, Hanke, C. A., Truitt, R L. (2001) Donor natural killer (NK1.1 +) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. Biol. Blood Marrow Transplant. 7, 589-595.